Teicoplanin Injection IP Vials | T-Planin - Glenmark

Advanced Glycopeptide Intravenous & Intramuscular Antibiotic When managing severe, hospital-acquired, or highly resistant Gram-positive bacterial infections, healthcare providers require an aggressive and targeted clinical intervention. The Teicoplanin Injection I.P. (commercially recognized as T-Planin) provides a highly potent glycopeptide antibiotic therapy designed strictly for clinical administration. Manufactured by Glenmark, a globally respected leader in pharmaceutical research, this sterile combipack ensures the steady clinical performance necessary for acute care and intensive recovery protocols.

Why Choose T-Planin for Critical Infection Management? Tackling challenging Gram-positive pathogens—including methicillin-resistant Staphylococcus aureus (MRSA)—requires a sophisticated approach. Clinical specialists benefit from T-Planin’s highly reliable formulation, which aggressively inhibits bacterial cell wall synthesis. This provides hospitals and specialized clinics with a gold-standard defense against complex skin, soft tissue, bone, and joint infections. Glenmark ensures the absolute, stringent quality control demanded in intensive care environments.

Key Product Specifications & Clinical Benefits

Potent Active Ingredient: Available in two distinct strengths to meet specific patient titration requirements—200 mg and 400 mg of premium-grade Teicoplanin per vial.

Complete Clinical Combipack: Each box is supplied as a convenient combipack containing the lyophilized Teicoplanin powder and a dedicated 5 ml FFS plastic ampoule of Sterile Water for Injections I.P., ensuring practitioners have the exact diluent on hand.

Versatile Delivery: Formulated safely for both Intramuscular (I.M.) and Intravenous (I.V.) use, giving practitioners flexible delivery methods based on patient protocols and acute care needs.

Lyophilized Stability: Supplied as a sterile, freeze-dried powder, ensuring maximum stability and potency of the active ingredient until the exact moment of clinical reconstitution.

Essential Storage & Usage Guidelines Maintaining the integrity of this critical care medication is vital for its clinical efficacy. Store the un-reconstituted combipack at a temperature below 25°C. Protect strictly from light and moisture. The sterile lyophilized powder should be used immediately after reconstitution. Any unused portion of the reconstituted solution containing visible solid particles must be discarded safely.

Important Notice: T-Planin is a Schedule H Prescription Drug. Caution: Not to be sold by retail without the prescription of a Registered Medical Practitioner. It must be prepared and administered strictly in a clinical or hospital setting. Keep all medicines safely out of the reach of children.